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Abstract 
 
In 2010-2012 new outpatient service locations were established in Hungarian micro-regions, 
which had lacked such capacities before. We exploit this quasi-experiment to estimate the 
effect of geographical accessibility on outpatient case numbers using both individual-level 
and semi-aggregate panel data. We find a 24-27 per cent increase of case numbers as a result 
of the establishments. Our specialty-by-specialty estimates imply that a one-minute reduction 
of travel time to the nearest outpatient unit increases case numbers e.g. by 0.9 per cent in 
internal care and 3.1 per cent in rheumatology. The size of the new outpatient capacities has a 
separate effect, raising the possibility of the presence of supplier-induced demand.  
By combining a fixed-effects logit and a fixed-effects truncated Poisson estimator, we 
decompose the effects into increases in the probability of ever visiting a doctor on the one 
hand and an increase of the frequency of visits on the other. We find that new visits were 
dominant in the vast majority of specialties, whereas both margins were important e.g. in 
rheumatology. Finally, we demonstrate the usefulness of the fixed-effects truncated Poisson 
estimator in modelling count data by examining its robustness by simulations. 
  
3 
 
1. INTRODUCTION 
Given the profound and inevitable informational asymmetry that is at the heart of the doctor-
patient relationship (Arrow, 1963), one perennial issue of health economics is: to what extent 
do considerations not related to health status affect diagnosis and therapy? These can come 
from the demand side (e.g. income, relative prices or accessability, i.e. time-related costs of 
seeking care for patients), as well as from the supply side (e.g. service providers’ incentives to 
provide more or less care than they would give themselves if they were in the shoes of their 
patients). This latter element also subsumes the hotly debated and highly policy relevant 
„supplier-induced demand” hypothesis that posits that, under certain monetary incentives (e.g. 
a fee-for-service environment), doctors might abuse their fiduciary position for their own gain 
by persuading patients to receive more or different care than what would be optimal according 
to the state-of-the art of medicine (Peacock and Richardson, 1999).  
Since geographical accessability (travel time to the location where care is provided) is clearly 
one of the possible determinants of the demand for health care (Acton, 1975), it is of great 
interest to identify its effect on the quantity of use. One empirical strategy to estimate such 
effects is to focus our attention on the regional variation in the distance to the location of care 
and the quantity of care given.  
Geographical variaton in the quantity of care, however, might also depend on the 
characteristics of the case. Skinner (2012), informed by economic theory and building on 
Wennberg et al. (2012), differentiates three groups of care: (1) „effective care” – treatments 
whose net value is universally high, and where therefore little geographical variation is 
expected; (2) „preference-sensitive treatments with heterogeneous benefits” – treatments 
where benefit is heterogeneous, net value is lower and where patient preferences and 
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physician skills and capacity constraints are more likely to produce differences in utilization 
rates across otherwise similar patients; and (3) „supply-sensitive care” – treatments where 
evidence promises negligible or zero effects. In case of types (2) and (3), we can expect and 
we do observe, cf. Skinner (2012), a lot of geographical variation that is hard to control for. 
Several empirical studies suggest that geographical accessibility to health care positively 
affects the use of health services and health outcomes (Campbell et al., 2000; Erlyana et al., 
2011; Haynes and Bentham, 1982; Hyndman et al., 2000; Lavy and Germain, 1994; Pathman 
et al., 2006). They are mainly based on cross-sectional variation in accessibility (an exception 
is Avdic, 2014), i.e. they compare the behaviour of population closer to the health service 
provider to those farther from it, controlling for health care needs (e.g. demographic factors). 
This procedure has the drawback that there may well remain unobservable factors (e.g. 
cultural patterns and other determinants that affect the quantity of non-effective care of type 
(2) and (3) as categorised above) that correlate with accessibility but at the same time 
influence health service utilization. In this case the effect of accessibility may be under- or 
overestimated due to the presence of unobserved variables (Wooldridge, 2010). Indeed, some 
cross-sectional studies yield counterintuitive estimates for the impact of accessibility on the 
use of health services (Bolduc et al., 1996).   
If access to health care improves substantially for a segment of the population, its effect can 
be directly examined by comparing the pre- and post-treatment behaviour of the affected 
population while controlling for other factors that may have influenced the change of health 
care utilization during the period. In this paper we exploit such a natural or quasi-experiment 
to identify how distance to health care affects the use of outpatient care services.2  
                                                          
2
 For a review of natural experiments in health economics see e.g. Jones (2009). 
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Hungary, an EU member state of 10 million inhabitants with a single-payer health insurance 
system and virtually universal coverage, expends 7.9% of its GDP on healthcare, 28% of 
which on outpatient care, our focus of interest here (2011 data, OECD, 2013). In the period 
we cover, responsibility for providing outpatient care was shared among municipalities, 
counties, the central government and private providers. The gatekeeping function of family 
doctors was non-exclusive. The basic benefit package (except for drugs) was (and is) free of 
out-of-pocket payments for the patients at the point of care, including outpatient care, albeit 
additional informal gratuity payments are widespread, especially in tertiary care. Most 
outpatient specialist services are financed by the budget based on fee-for-service points, under 
a system that scores procedures on the basis of their complexity and resource requirements. 
The relatively high share of outpatient care in provision and financing is due to the heritage of 
the Semashko-type model of healthcare provision under Soviet dominance. Central to that 
original universal model was a multi-tiered system of care with a strict referral system and 
strongly differentiated network of service providers, with outpatient specialist care one of the 
distinct tiers of healthcare provision (Gaál et al., 2011; Kornai and Eggleston, 2001).   
Between 2010 and 2012 around 430 thousand people gained better access to specialist 
outpatient care in Hungary when the government created outpatient units in 20 rural micro-
regions, which previously lacked capacity. (The investments were funded by the Social 
Infrastructure Operative Programme [SIOP] 2.1.2. of the European Union.) Locations for the 
new units were selected based on the applications of municipalities with no or limited local 
capacity to provide such care, making a case for need and demand. Funding accounted for 
500-1000 million forints (2-4 million euros) per unit, generally covering 90-95% of the costs 
of the establishment of the new units to the municipalities if they complied with a set of 
administrative requirements (e.g. providing a minimum of services for a minimum of 
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hours/month, keeping the unit in operation for at least five years). While competition for 
scarce funds was not an issue (sufficient funds were allocated to be able to subsidize all likely 
applicants eligible under those rules; in fact the call stipulated that up to 25 municipalities 
could be awarded funding), there may have been self-selection by eligible municipality based 
on willingness to apply for funding. We have no administrative data on where the physicians 
hired to staff the new units were recruited from, but interviews suggested that many commute 
from nearby urban centres (Hétfa et al., 2013). The newly created units (all still in operation 
as of 2014) provide comprehensive service for the population of the micro-regions with at 
least 14 separate specialties at each location, although the number of consultation hours is 
generally low. As a result, basic specialist outpatient care (which we define as outpatient care 
in the following four specialties: internal medicine, surgery, obstetrics-gynecology and 
pediatrics) may now be reached by around 310 thousand more people by car in 20 minutes 
than before. (At least 1.6 million people – or 16 per cent of the population of Hungary – still 
live beyond this 20 minute limit.)  
At the same time, other parts of Hungary experienced relatively few changes in the 
management of outpatient care between 2008 and 2012. Hence an appropriate control group 
of micro-regions can be identified, in which the health care indicators may be compared to 
those in the micro-regions where new outpatient service locations were established (the 
„treated” micro-regions). The geographical location of the treated and control micro-regions 
across the country is shown in Figure 1. The impact of the improvement in accessibility can 
then be estimated as the difference between the changes in the treated and control groups. We 
use both individual (micro-level) case statistics, which are analysed in a fixed-effects Poisson 
regression framework, and semi-aggregate data (measured at the micro-regional level), which 
are analysed in a fixed-effects linear panel regression setting. 
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(Figure 1 about here) 
The micro-level data enable us to examine the heterogenous impact of the establishment of 
new outpatient locations on the various age groups and genders, as well as to identify the 
separate effects of supply-side factors such as the size of the new capacities. Furthermore, by 
taking into account that patients living in different settlements faced different improvements 
in travel time, we give a structural interpretation of our results by estimating the effect of a 
one minute change in travel time by car to the nearest outpatient care provider on health care 
use. These structural parameters can be used for ex ante evaluation of the impact of future 
health care investments. 
Finally, we decompose the overall effect on case numbers into those happening on the 
„extensive” and the „intensive” margin, i.e. into „new patients” and the visiting frequency of 
existing patients. Following the approach of Majo and van Soest (2011), we use the fixed-
effects logit model for the extensive margin and the fixed-effects truncated Poisson model for 
the intensive margin. We demonstrate by Monte Carlo simulations that the fixed-effects 
truncated Poisson estimator has certain robustness properties: it appears to be consistent not 
only if the conditional distribution is indeed truncated Poisson but even if it is a mixture of 
truncated Poisson distributions with the same mixing distribution across periods. This 
contains the truncated negative binomial distribution as a special case.          
The paper is organised as follows. Section 2 introduces the data and Section 3 the 
econometric estimation methods. Results are presented in section 4 and discussed in section 5. 
Some details of the data sets and of the properties of the fixed-effects truncated Poisson 
estimator are given in the Appendices. 
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2. DATA    
In most of our analysis we use a detailed event-level database exclusively provided to us for 
this research project by the National Institute for the Quality and Organizational Development 
in Healthcare and Medicines (GYEMSZI), which contains administrative information on 
individual visits to specialist outpatient units.3 Based on the specialty of the corresponding 
outpatient unit, we first classify each visit to one of 18 specialty groups (which are shown in 
Table III and will be referred to as specialties below). Then, for each specialty – and also for 
all specialties summed up – we construct a patient-level panel database that contains the 
number of outpatient cases by person for a 25 per cent random sample of the residents of 20 
treated and 21 control micro-regions for each quarter between 2008 and 2012. Age, gender of 
the patient and the postcode of her residence are also recorded.  
Due to legal reasons, data on whole Hungary could not be obtained, therefore 21 control 
micro-regions (out of the 138 rural-type micro-regions, which are outside the most developed 
Central Hungary and do not coincide with a chief town of a county) were selected with the 
aim of approximating the observed characteristics of the 20 treated micro-regions as closely 
as possible. Specifically, the control group was chosen on the basis of the treatment 
propensity score, estimated from a logit model on the micro-regional level: 
 (1) Pr ∈ 	
 =Λ,  
where k denotes the micro-region,  its pre-treatment (year 2008) demographic, socio-
economic and health characteristics, and Λ is the logistic function. 
                                                          
3 The data set went through initial data cleaning and transformation, see online Appendix 2 for details. 
9 
 
The estimated parameters of the logit model are presented in Table A1 in online Appendix 2. 
The most important explanatory variable of treatment propensity is the number of specialist 
outpatient consulting hours per 1000 inhabitants before the SIOP 2.1.2. projects. As 
mentioned earlier, only micro-regions without any substantial outpatient capacity could 
receive these grants.  
The control group was defined by all non-treated micro-regions with a propensity score 
greater than 0.08. Estimating regressions on a sample pre-filtered on the basis of the 
propensity score is a usual practice in statistics (see e.g. Angrist and Pischke, 2009) and we 
roughly followed the advice of Crump et al. (2009) in the pre-filtering procedure.4 As Table 
A1 shows the balancing of the explanatory variables between the treated and the control 
group is satisfactory: the means of the variables are roughly the same and do not differ 
significantly in the two groups. For instance, the number of weekly specialist outpatient 
consultation hours per 1000 residents – for which the highest treated-control differences are 
observed – average to 0.6 in the treated and 1.2 in the control micro-regions, but the latter is 
still less than one third of the average value of all non-treated micro-regions (3.8), and the t-
statistic of the treated – control difference is not significant. Altogether, 430 thousand people 
live in the treated and 525 thousand people in the control micro-regions.   
Out of the newly set-up outpatient services, 14 started to operate in 2011 (the earliest start was 
September 2010 and the latest was May 2012), hence sufficiently long pre- and post-treatment 
periods exist in the panel database between 2008 and 2012. 
                                                          
4 As a rule of thumb, Crump et al. (2009) propose to restrict the sample to units with a propensity score between 
0.1 and 0.9. Since in our case the largest propensity score did not differ much across the treated (0.96) and non-
treated (0.89) micro-regions, we only restricted the propensity score from below in order to keep all treated 
micro-regions in the sample.   
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As a robustness check, we use another, micro-regional panel data sets (obtained from the 
National Health Insurance Fund [OEP]) that contain for each specialty the semi-aggregate 
number of outpatient cases by month and by micro-region for 56 months (between January 
2008 and August 2012) and for 138 rural-type micro-regions (where the micro-regional 
classification is given by the residence of the patient). The original source of these data is the 
same event-level database as of the patient-level panel data. It is aggregated to the micro-
regional level but covers a much wider population (around 4.8 million people) than the 
patient-level panel database that could be obtained only for the treated and control micro-
regions. 
3. METHODS 
3.1. Estimating the overall effect 
Our main identifying assumption is that the changes of case numbers in the treated and 
control micro-regions would be the same in the absence of treatment – apart from some time-
varying characteristics of the micro-regions that we can control for. Since the treated and 
control micro-regions are observationally similar (see Table A1), this is a reasonable 
assumption. Moreover, interactions between the treated and control group are likely to be 
negligible because there is only a small number of treated and control micro-regions with 
common borders (see Figure 1) and, in any case, the vast majority (around 90 per cent) of the 
patients of the new specialist units come from their own micro-regions.5 
                                                          
5
 Note also that any interaction effect would cause a downward bias on the impact estimates because the case 
numbers of the residents – and not of the specialist units – are compared. 
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As noted earlier, we examine the panel data sets of different specialties separately. Formally, 
let  denote the number of outpatient cases of person i in quarter t in a particular specialty or 
in all specialties summed up. Its expected value may depend on some observable ( and 
unobservable ( characteristics of the person and the micro-region.  includes the 
treatment dummy or other treatment indicators, which are of primary interest, and  allows us 
to control for all time-invariant patient-level determinants, which may also include micro-
regional characteristics. Since  is a count of events and it is measured in a panel dataset 
where the distribution of  and its relationship with  may in principle be arbitrary, a fixed-
effects Poisson regression framework is appropriate here. In this setting the conditional 
expectation of  is modelled as 
(2) |,  = exp	 + . 
Wooldridge (1999) proved that the conditional maximum likelihood estimator of this model, 
constructed by assuming a Poisson distribution and eliminating  from the likelihood 
calculations, has nice robustness properties: it is consistent under the weak assumption that 
the conditional mean function (2) is well specified. Hence not only an entirely unrestricted 
relationship may exist between  and the observables, the conditional distribution of  and 
the dependence across time within a cross-sectional unit can also be arbitrary. (However, the 
standard errors should be adjusted in the more general cases.6) Due to these robustness 
                                                          
6 In our case, in addition to these adjustments, the standard errors should also be adjusted (by bootstrapping) to 
take into account the propensity score based pre-filtering. However, since the bootstrap and usual standard errors 
generally differ only slightly, this adjustment is rarely done in practice (see e.g. Angrist and Pischke, 2009). 
Without micro-data outside the treated and control micro-regions, we could not perform the bootstrap procedure 
in the fixed-effects Poisson regression. However, as a robustness check, we replicated the propensity score based 
pre-filtering and the bootstrap calculations in the fixed-effects panel regression on the semi-aggregate data set 
(see below) and found that the bootstrap and usual standard errors are almost identical.            
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properties, the fixed-effects Poisson model is a basic model in the analysis of panel count 
data.7 
We use various model specifications to analyse the heterogenous effect of the treatment on 
different groups of patients and to exploit the heterogeneity of treatment itself. In our baseline 
model  = , ,  , where  is the treatment dummy8,  is the vector of time 
(quarter) dummies, and   is the vector of time-varying controls measured at the micro-
regional or individual level such as the age group of the patient: 
(3) |, ,  ,  = exp	! +	" +  # + . 
Hence we have a difference-in-differences-type (DiD) specification, where the expectation is 
modelled on a multiplicative scale. !, the parameter of primary interest, gives the 
approximate percentage impact of the treatment on case numbers, while " controls for the 
change of case numbers independent of the treatment during the period, and  controls for the 
differences in the initial level of case numbers in various micro-regions and between patients.        
In the interaction model we include the interaction of  with age group dummies ($%&' and 
$&(%)* for the 0-17 and 18-59 years groups, respectively), with gender (+ for females) and 
with the dummy for living in the chief town (,) in the conditional expectation equation. 
Here the parameters of the interaction terms measure the heterogenous effect of the treatment 
on various groups: 
                                                          
7  See e.g. Wooldridge (2010) for some applications. 
8
 D./=1 if a new outpatient unit operates in the micro-region of patient i in period t (and D./=0 otherwise). In a 
variant of the baseline specification – not reported in the paper – the one-year lagged values of  were also 
included but the lagged parameter was insignificant suggesting that case numbers were affected by the treatment 
quite rapidly. 
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(4) |, $%&', $&(%)*, +, , , ,  ,  = exp	! + $%&'!0%&' +
$&(%)*!0&(%)* + +!1 + ,!2 +	" + # + . 
To gain insight into the health economic reasons behind the increase in case numbers, our 
capacity model expands the baseline specification with the size of the new outpatient 
capacities (per 1000 inhabitants of the micro-region) in the given specialty, denoted by 3. Its 
parameter measures the effect of the size of the new capacities after controlling for the mere 
existence of new units: 
(5) |, 3, ,  ,  = exp	! + 34 +	" +  # + . 
Finally, to exploit the heterogeneity in the reduction of travel time, we define 5 as the travel 
time (in minutes) needed to reach the nearest outpatient unit of the given specialty by car from 
the settlement of person i in quarter t.9 In the given period the change of 5 is negligible in 
the control micro-regions compared to that in the treated micro-regions and there is a 
substantial variability within the treated group as well. The parameter 6 in our structural 
model shows the percentage increase of the number of outpatient cases as a result of a one-
minute reduction of travel time to the nearest outpatient unit: 
(6) |5,  ,  ,  = exp	56 +	" +  # + . 
As a robustness check of the results from the individual-level data, we also estimate the 
treatment effect on the semi-aggregate (micro-regional) panel data containing all 138 rural-
type micro-regions in Hungary. Let 7 denote the aggregate number of outpatient cases in 
micro-region k and month t. This is affected by the time-invariant (or slowly varying) 
characteristics  of the micro-region (such as the referring behaviour of the local GP) and by 
                                                          
9  These data come from a distance matrix of travel times between all settlements in Hungary, provided by 
GYEMSZI. 
14 
 
observable micro-regional characteristics  = , ,  . Here,  is again the 
treatment dummy,  now contains trend and seasonality, and – to control for the 
heterogeneity of the micro-regions –  	includes the local unemployment rate. Our model is 
then:  
 (7) log7 = ! + " +  # +  + ;, 
where ; is the (time-varying) error term. The model is estimated by fixed effects (FE linear 
regression), which allows the  unobserved characteristics to be arbitrarily correlated with 
. Since the dependent variable is in a logarithmic form, the parameters of the treatment 
dummies in (3) and (7) are directly comparable.  
3.2. A hurdle model for separating the extensive and intensive margins  
Micro-level data allow us to separate the extensive margin of adjustment (i.e. the change of 
the probability of ever visiting an outpatient provider) and the intensive margin (i.e. the 
change in the frequency of visits). Since the decisions whether to use a health service at all 
and how much to use it are possibly governed by different forces, hurdle (two-part) models 
that can separate the two margins have been long in use in health economics (e.g. Bago 
d’Uva, 2006; Jones, 2009; Pohlmeier and Ulrich, 1995; Winkelmann, 2004). In a hurdle 
setting, the random event { > 0} and the random variable conditional on this event 
@| > 0A are modelled directly. Certain authors prefer zero-inflated or finite mixture 
models, where the zero and non-zero parts of the distribution come as mixtures of two (or 
more) latent classes of patients with different underlying intensity to use health services (e.g. 
Deb and Trivedi, 2002; Jones, 2009). In any case, the extension of such models to panel data 
is far from straightforward: on the one hand, serious computational difficulties may arise in a 
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random-effects framework (Cameron and Trivedi, 2013), on the other hand, conditioning out 
the fixed-effects similarly to the Poisson-case above is rarely possible. In this paper we use a 
pragmatic approach to model the two hurdles in a fixed-effects setting.       
First the extensive margin is analysed by a fixed-effects logit model:  
(8) Pr > 0|, B =Λ	B + B, 
where Λ is the logistic function,  now contains the treatment dummy ) along with the 
usual control variables (,	 ), and B denotes the unobserved heterogeneity of person i 
associated with his / her propensity to visit the doctor at least once a year. The fixed-effects 
logit estimator is consistent without particular assumptions about the distribution of B or 
about its relationship with the explanatory variables, hence it is applied very often in 
econometrics (Wooldridge, 2010).             
Second, following and completing the work of Majo and van Soest (2011), we model the 
intensive margin in a fixed-effects truncated Poisson framework, where our inference is based 
solely on the positive part of our sample. As a starting point, suppose that in a panel data set 
we observe C&, CD, … , CF, which are independent zero-truncated Poisson random variables, 
conditionally on  and on the unobserved heterogeneity G (which is now associated with 
the visiting frequency to the doctor.) That is, we observe the non-zero part of the count data. 
The probability mass function of C is given by    
(9) PrC = |, G = HIJK /!∗OPQ%HIJ&%OPQ%HIJ          = 1,2, … , 
where  
(10) T = exp	G + G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is the conditional expectation of the corresponding untruncated Poisson distribution. Then, as 
already noted by Majo and van Soest (2011), the distribution of C&, CD, … , CF, 
conditionally on their sum, does not depend on G and hence – similarly to the fixed-effects 
Poisson regression – a fixed-effects regression framework is applicable in the truncated case, 
too. Based on the fact that the joint distribution of independent truncated Poisson random 
variables, conditional on their sum, is truncated multinomial (see e.g. Johnson et al., 1997, p. 
32), we derive the conditional (fixed-effects) likelihood and prove the consistency and 
asymptotic normality of the fixed-effects estimator in the truncated Poisson setting in 
Appendix 1. Hence, in contrast to other fixed-effects truncated regression models 
(Wooldridge, 2010), in the truncated Poisson case there is no need to apply various advanced 
(e.g. semiparametric) estimators because the standard conditional maximum likelihood 
estimator is consistent.    
Appendix 1 proves consistency and asymptotic normality under the assumption that the model 
is well-specified, i.e. that the joint distribution of C&, CD, … , CF is indeed independent 
truncated Poisson with the specified conditional expectation. As noted in section 3.1., the 
usual fixed-effects (untruncated) Poisson estimator is much more robust than this because its 
consistency requires only a well-specified conditional expectation (while the distribution can 
be entirely unrestricted). We demonstrate by Monte Carlo simulations in online Appendix 3 
that the truncated estimator also has some robustness properties: for U = 2 it is consistent 
even when C is a mixture of truncated Poisson distributions, with the same mixing 
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distribution across periods.10 By choosing the gamma distribution as the mixing law, this 
contains the truncated negative binomial distribution as a special case.    
Returning to our hurdle model to separate the extensive and intensive margins, we may 
assume that @| > 0A comes from a truncated Poisson (or Poisson-mixture, see above) 
distribution with untruncated expected value given by equation (10). Then, because of the 
unknown number of zeros, ∑ FW&  is not a sufficient statistic for G, but it is sufficient on 
the subsample of positive values { > 0}. Hence we may estimate the intensive margin by 
the fixed-effects truncated Poisson estimator on this subsample. (Thus e.g. if U = 2, 
estimation is carried out on units that take positive values in both periods.)   
Alternative approaches would be Deb and Trivedi’s (2013) fixed-effects expectation-
maximization (EM) framework or the various random-effects estimators of hurdle, zero-
inflated or finite mixture models (Cameron and Trivedi, 2013; Jones, 2009). These 
approaches are, however, computationally intensive and the latter kind of models are not 
robust to distributional misspecifications in the unobserved heterogeneities, either. Hence, in 
this paper we opt for the combination of fixed-effects logit and truncated Poisson estimators 
to provide a flexible way to separate the two margins.  
In addition, as a robustness check, we display results from a simple pooled zero-inflated 
negative binomial model, where the case numbers are modelled as a mixture of a zero 
distribution and a negative binomial distribution (whose expectation depends on the 
covariates), and the mixing probability is given by a logit formulation also depending on the 
covariates (see Wooldridge, 2010). Although – compared to a random-effects or fixed-effects 
setting – in the pooled version we do not model the clustering of the unobserved 
                                                          
10 To ensure that equation (10) for the untruncated expectation still holds, the mixing distribution should have a 
unit expected value. 
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heterogeneities explicitly, the maximum likelihood parameter estimates of this model are still 
consistent if the distributions are correctly specified and if the unobserved individual 
heterogeneities are independent of the covariates. (If balancing is satisfactory between the 
treated and control micro-regions, the latter assumption seems reasonable. In any case, 
cluster-robust standard errors should be used in the pooled model.) Note also that the zero-
inflated and the hurdle model are not directly comparable because in the zero-inflated 
formulation  takes a positive value only if the observation is not in the zero mixture and 
the negative binomial distribution takes a positive value.          
Due to the large number of zero visits on the quarterly frequency, we fit the hurdle and zero-
inflated models to annual data. To avoid problems with years split by the different 
commencement of the new units, we use one pre- and one post-treatment year: 2009 and 
2012. 
4. RESULTS 
4.1. Descriptive analysis 
By opening the new outpatient units, accessibility to outpatient services dramatically 
improved in their respective micro-regions. For instance, the average travel time by car for the 
residents of the treated micro-regions from their settlement to the nearest unit in internal 
medicine decreased from 19.8 minutes in 2008 to 9.8 minutes in 2012. Meanwhile, the 
accessibility from the control micro-regions remained unchanged (15.8 minutes on average).  
As a result of the new outpatient service locations opening their doors, the patients quickly 
started to use them. Table I shows that in May-August 2012 around 35-45 per cent of internal 
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care, surgery and obstetrics-gynaecology cases coming from the micro-regions in which new 
specialties were set up were treated by new providers, while this ratio was around 60 per cent 
for patients of the chief towns (where the new units operate). Meanwhile, patient paths in 
paediatrics did not divert substantially. 
(Table I about here) 
As a descriptive analysis of the impact of the treatment, Table II displays the standardized 
number of outpatient cases in the May-August periods of 2010 and 2012 for the treated micro-
regions and for those „rural” micro-regions, where non-negligible outpatient capacity existed 
already before 2010. The data show a dramatic increase in case numbers for the treated micro-
regions. While the numbers were well below those of the similar micro-regions in 2010, they 
increased to roughly that level after the developments. This already suggests that the absence 
of the supply in a micro-region had a clear negative impact on outpatient care use.    
(Table II about here) 
4.2. Estimation results 
Econometric methods that control for other factors influencing case numbers during the 
observational period display a similar picture to the descriptive analysis. Table III shows that 
the new units established under SIOP 2.1.2. increased outpatient case numbers by 24-27 per 
cent, and this result is robust across the two (individual-level and semi-aggregate) datasets 
and estimation methods.11 Looking at separate specialties, rheumatology experienced the 
largest increase (55 per cent according to the micro-data), which is not surprising, given the 
                                                          
11
 See also Table A2 in online Appendix 2, which displays raw quarterly case numbers by patient between 2010 
and 2012: a rapid increase in the treated micro-regions and no change in the control micro-regions can be 
observed. 
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large non-financial costs rheumatology patients are facing when they need to travel to an 
outpatient provider. The establishment of new outpatient locations had a limited impact on 
paediatrics cases, in line with the descriptive analysis of patient paths presented above.           
(Table III about here)  
Table III also shows the results of our capacity model (equation (5)), where the relative size of 
the capacities 3 appears along with the treatment dummy . In some specialties – notably 
in internal care, traumatology, dermatology, rheumatology, psychiatry, pulmonology, 
cardiology and ultrasound – the size of the new capacities has a significant and substantial 
impact (beyond the mere existence of the new unit) on outpatient case numbers. On the other 
hand, no such effect is present e.g. in surgery, obstetrics-gynaecology or urology. The positive 
impact of the size of the new capacities suggests the presence of supplier-induced demand but 
the role of patient-side mechanisms (e.g. through reduced waiting lists) cannot be ruled out, 
either. On the other hand, if the size of the capacities does not play a role in a particular 
specialty, that makes the presence of supplier-induced demand unlikely there. Note also that 
the mere existence of new units (the parameter of ) is significant in the vast majority of 
specialties.             
According to the interaction model (equation (4)), the effect of the treatment on the total 
number of cases (taking all specialties together) is significantly higher for women than for 
men (by 3.9 percentage points, i.e. !1 = 0.038 in equation (4)), and lower by 7.3 percentage 
points for patients between 18-59 years and by 16.0 percentage points for patients under 18 
years than for patients above 60 years.12 Gender- and age-specific estimates on the specialty 
                                                          
12 See also Table A2 in online Appendix 2 for the gender- and age-specific average case numbers in the treated 
and control micro-regions between 2008 and 2012. 
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level, however, do not paint a consistent picture, so we do not display the detailed results 
here. 
To exploit variability in the reduction of travel times, Table IV shows the estimated 
percentage impact of a one-minute reduction of travel time for various specialties (calculated 
from the estimated parameter 6 in our structural model (equation (6))). For instance, for 
internal care, a one-minute reduction of travel time increases the number of cases by 0.9 per 
cent. The highest values are estimated for rheumatology (3.1 per cent), surgery and 
dermatology (1.8-2.0 per cent).        
(Table IV about here) 
4.3. Separating the extensive and intensive margins 
Table V displays the estimates of the extensive and intensive margins from both the fixed-
effects hurdle and the pooled zero-inflated negative binomial model. Although these models 
are not equivalent and hence their results slightly differ, both indicate a large and significant 
positive impact on the extensive margin in the vast majority of specialties. The impact in the 
median specialty is around 0.25 on the logit scale, which is substantial in per cent increase 
because the median annual visiting probability was only 0.08 before the treatment in the 
treated micro-regions. On the other hand, the effects on the intensive margin are rather small 
and insignificant, with substantial impact measured only in surgery, dermatology, 
rheumatology and laboratory diagnostics. But even in these specialties the adjustment on the 
extensive margin seems to exceed that on the intensive margin.     
(Table V about here) 
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5. DISCUSSION 
In this paper we considered the opening of new outpatient care locations a quasi-experiment 
in order to analyse the effects of geographical accessibility on the quantity of care. Our data 
and estimation methods made it possible to separate the utilization effects of bringing care 
closer to the patients from the effects of many other determinants of utilization that exhibit 
geographical variation. The internal validity of our findings (the similarity of our results 
across two different data sets and estimation methods) seems convincing. As far as external 
validity is concerned, our findings are hard to compare since the literature consists of cross-
sectional analyses rife with inevitable endogeneity problems. Nevertheless our results are 
roughly comparable with those found e.g. by Erlyana et al. (2011) from cross-sectional survey 
data in Indonesia. 
We obtained significant estimates for how much a one-minute reduction of travel time 
increases the number of cases across different specialties of care (e.g. 0.9 per cent for internal 
medicine, but 3.1 per cent for rheumatology). The fact that the visits in rheumatology are the 
most affected by the need to travel can be explained by the additional pain and effort 
associated with the movement of rheumatology patients. By combining the fixed-effects logit 
and the fixed-effects truncated Poisson estimators, we could also decompose the effects of a 
change in accessibility on case numbers into increases in the probability of ever visiting a 
doctor on the one hand and an increase of the frequency of visits on the other.    
Telling apart impacts on the extensive and intensive margin (the results in Table V) and 
identifying impacts net of the effect of an increase in the size of outpatient capacity 
(parameter of the pure treatment dummy in the capacity model of Table III) also goes a long 
way towards separating an increase in the number of cases that represent an unambiguous 
23 
 
increase in social welfare (“effective care”) from cases where the suspicion of the 
intensification of supply-sensitive care arises. The latter would manifest itself in an increased 
visit frequency, not in a higher number of previously untreated patients seeing the doctor. 
While our specifications cannot directly prove the presence of supplier-induced demand, our 
results can and do point towards it in some specialties, where more outpatient capacity (to be 
filled by doctors in search of increased funding for more fee-for-service points) partially 
explained the increase in the number of cases. Our main result, however, is that we could 
identify significant increases in the number of cases even net of that effect, and on the 
extensive margin. We argue that these increases unambiguously represent “effective care” as 
defined in Skinner (2012). In other words, our results do not just show that, thanks to the 
shortened travel time to the specialist, more people decide to see the doctor with their 
symptoms, but also that it is more likely to lead not just to higher state and private health 
costs, but to earlier diagnosis and treatment as well. Thus, if follow-up studies can prove that 
the effects we found are indeed durable and impact health outcome variables as well, we can 
deduce that improving access can be a way to geographically target areas with low health 
status and thereby to reduce health inequality. 
In fact, our results, if complemented with estimates of the long run health effects and the fixed 
and variable costs of establishing such rural outpatient units, could be used by policy makers 
to carry out an ex-post social cost-benefit analysis of the project, and, with careful validation, 
our structural parameters could also contribute to ex-ante estimations helping responsible 
healthcare investment decisions elsewhere as well. 
One potential use of our findings could be to consider the time and monetary cost of distance 
travelled to see the doctor an element of the price of the service and estimate the own-price 
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elasticity of demand for the frequency of healthcare intervention in a two-part healthcare 
service demand specification. Such a demand function could shed light on the benefits of 
more frequent ambulatory healthcare services as perceived by the patient.  
Finally, as a methodological advancement, we demonstrated that the combination of fixed-
effects logit and truncated Poisson estimators provide an attractive choice for analysing panel 
count data because they are computationally much less challenging to estimate in large data 
sets than their competitors and they have certain robustness properties.    
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TABLES AND FIGURES 
 
Figure 1: Geographical location of the treated and control micro-regions  
and the distribution of specialist outpatient consulting hours in Hungary   
 
Source: TSTAR (settlement) data; OEP data on specialist outpatient hours in the four basic specialties combined  
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Table I: The ratio of cases treated in the micro-region of residence among the cases of the 
population of the treated micro-regions (per cent)   
 
Among the whole population of 
micro-regions  
Among the population of the micro-
regional chief towns 
 Average Minimum Maximum Average Minimum Maximum 
Internal care 35.8 13.7 68.9 55.0 18.9 77.8 
Surgery 43.8 14.3 65.3 64.4 32.2 83.4 
Gynaecology 43.9 17.0 80.1 64.2 22.8 87.5 
Paediatrics 11.6 1.2 35.4 18.7 3.0 49.8 
Source: own calculations based on semi-aggregate OEP data 
Note: The data refer to the period between May 2012 and August 2012, excluding the new unit in 
Baktalórántháza (which started in May 2012).  
 
 
Table II: Number of outpatient cases (as a proportion of 100 inhabitants) in the SIOP 2.1.2. 
micro-regions and similar micro-regions with substantial oupatient capacities before 
Number of cases  
/ 100 inhabitants 
 
Age groups (years) 
Average 
Standardized 
(for age 
distribution) 
Difference 
(treated – 
similar) 0-17 18-59 60+ 
SIOP 2.1.2. micro-regions 
2010  204 354 480 350 355 -21.5% 
2012 242 443 706 457 465 1.3% 
Similar micro-regions 
2010 258 437 645 452 452  
2012 251 426 712 459 459  
Source: own calculations based on semi-aggregate OEP data 
Note: The term „similar micro-region” refers to those micro-regions that had at least 200 hours of specialist 
monthly outpatient capacity already in 2010 and are outside Central Hungary and not in a chief town of a county. 
(Hence they are not the same as the control micro-regions.) Outpatient cases are defined after excluding 
laboratory diagnostics and special one-day services. Annualized rates are shown on the basis of the May–August 
periods (without adjusting for seasonality). The standardized proportions were calculated based on the age 
distribution of the similar micro-regions.        
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Table III: Impact of SIOP 2.1.2. treatment on the number of outpatient cases  
(baseline and capacity models)  
 
Model on  
semi-aggregate  
data 
Models on micro-level data 
 Baseline models Capacity model Number  
of obs. 
(thousand) 
Number  
of groups 
(thousand) 
 
FE linear model 
(equation (3)) 
FE Poisson model 
(equation (7)) 
FE Poisson model  
(equation (5)) 
 
Effect in per cent exp! − 1 
(with S.E.) 
Parameter of 
treatment dummy (!) 
(with S.E.) 
Parameter of 
capacities (4) 
(with S.E.) 
All specialties 26.7*** (2.8) 24.2*** (0.8)     3773.3 198.9 
Internal care 14.2*** (4.2) 11.7*** (1.3) 0.051** (0.025) 0.054*** (0.020) 1317.4 68.8 
Surgery 39.7*** (5.2) 35.7*** (2.5) 0.268*** (0.036) 0.037 (0.034) 1113.2 57.8 
Traumatology 19.0** (8.0) 10.2*** (2.7) -0.046 (0.049) 0.307*** (0.095) 966.1 49.9 
Gynaecology 22.5*** (4.1) 12.4*** (1.9) 0.085*** (0.031) 0.032 (0.027) 895.3 45.8 
Paediatrics 5.3 (4.5) 4.8** (2.2) -0.012 (0.036) 0.199* (0.102) 493.7 27.3 
Otolaryngology 32.0*** (6.8) 29.0*** (2.4) 0.204*** (0.043) 0.104 (0.077) 1052.5 54.9 
Ophtalmology  34.3*** (3.1) 25.1*** (1.7) 0.218*** (0.029) 0.008 (0.036) 1273.7 65.5 
Dermatology 39.1*** (8.8) 34.0*** (2.8) 0.183*** (0.037) 0.227*** (0.064) 885.1 45.7 
Neurology 28.1*** (4.1) 23.9*** (2.1) 0.173*** (0.045) 0.088 (0.088) 671.2 35.1 
Orthopaedy 40.6*** (4.6) 25.6*** (3.0) 0.196*** (0.045) 0.110 (0.130) 547.3 29.7 
Urology 20.2*** (3.8) 15.5*** (2.7) 0.151*** (0.047) -0.024 (0.143) 478.7 24.9 
Rheumatology 88.3*** (16.8) 55.4*** (3.0) 0.192*** (0.037) 0.351*** (0.044) 906.9 46.8 
Psychiatry 16.1*** (3.9) 17.7*** (2.9) 0.054 (0.063) 0.163** (0.071) 384.9 20.0 
Pulmonology -1.3 (5.3) -4.3*** (0.9) -0.087*** (0.014) 0.082*** (0.021) 2140.6 109.9 
Cardiology 31.0*** (7.7) 19.5*** (2.1) 0.082** (0.036) 0.187*** (0.063) 625.5 32.6 
Lab diagnostics 14.5* (7.9) 8.9*** (2.5) 0.075*** (0.026) 0.056 (0.083) 1465.9 76.9 
X-ray 25.9*** (3.9) 11.0*** (1.1) 0.118*** (0.023) -0.020 (0.028) 2472.9 129.5 
Ultrasound 19.0*** (4.9) 7.7*** (1.3) -0.070*** (0.027) 0.209*** (0.034) 1654.8 87.4 
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Source: own calculations based on micro-level (GYEMSZI) and semi-aggregate (OEP) data 
***: p<0.01; **: p<0.05; *: p<0.1 
Note: All results refer to outpatient cases excluding special one-day services. Robust standard errors are in parentheses. 
For baseline models: percentage effects (and not the actual coefficients) are displayed.  
FE linear model on semi-aggregate data: fixed-effects linear model on monthly log case numbers by the micro-region of patients (from „rural-type” micro-regions) between 
January 2008 and August 2012. Controls: linear trend, seasonality, unemployment rate of micro-region, the presence of other minor (SIOP 2.1.3. and RDOP) development in 
outpatient service. Number of observations: 138 micro-regions x 56 months.   
FE Poisson models on micro-level data: fixed-effects Poisson models on quarterly case numbers by patient (living in treated or control micro-regions) between 2008 and 
2012. Explanatory variable in the baseline model: treatment dummy (). Explanatory variables in the capacity model:   and the size of the new outpatient capacities (3). 
Controls: time (quarter) dummies and age groups. Number of groups (patients) and observations (patient x quarter) are shown, excluding people with zero case number across 
all periods in a given specialty. 
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Table IV: Impact of a one-minute reduction of travel time on the number of outpatient cases 
 (percentage changes) 
Specialty 6 in equation (6) 
(with S.E.) 
Number of  
of obs. 
(thousand) 
Number  
of groups 
(thousand) 
Internal care 0.953%*** (0.076%) 1316.2 68.8 
Surgery 1.951%*** (0.108%) 1112.2 57.7 
Traumatology 0.934%*** (0.128%) 965.4 49.9 
Gynaecology 1.084%*** (0.106%) 894.3 45.8 
Paediatrics 0.450%*** (0.101%) 493.4 27.2 
Otolaryngology 1.607%*** (0.109%) 1051.5 54.9 
Ophtalmology  1.499%*** (0.087%) 1272.3 65.4 
Dermatology 1.813%*** (0.120%) 884.3 45.7 
Neurology 1.440%*** (0.103%) 670.6 35.1 
Orthopaedy 1.568%*** (0.132%) 546.7 29.7 
Urology 1.242%*** (0.123%) 478.2 24.9 
Rheumatology 3.111%*** (0.122%) 906.1 46.8 
Psychiatry 1.124%*** (0.108%) 384.6 20.0 
Pulmonology -0.348%*** (0.054%) 2138.8 109.9 
Cardiology 0.980%*** (0.094%) 624.9 32.6 
Lab diagnostics -0.307% (0.225%) 1464.2 76.8 
X-ray  0.930%*** (0.054%) 2471.2 129.5 
Ultrasound 0.778%*** (0.069%) 1653.5 87.4 
Source: own calculations based on micro-level (GYEMSZI) data 
***: p<0.01; **: p<0.05; *: p<0.1 
Note: All results refer to outpatient cases excluding special one-day services. Robust standard errors are in 
parentheses.  
Model: fixed-effects Poisson model on quarterly case numbers by patient (living in treated or control micro-
regions) between 2008 and 2012. Percentage impacts of a one-minute reduction are displayed (calculated from 
the estimated parameter of 5). Controls: time (quarter) dummies and age groups. Number of groups (patients) 
and observations (patient x quarter) are shown, excluding people with zero case number across all periods in a 
given specialty. 
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Table V: Impact on the visiting probability and visiting frequency 
 FE hurdle model Pooled zero-inflated negative binomial model 
 Extensive margin Intensive margin Extensive margin Intensive margin  
 FE logit 
equation (8) 
FE truncated Poisson 
equation (10) 
Logit for  
the probability of  
the negative binomial part 
Log expectation for  
the negative binomial part 
 
 
parameter of D./ 
No. of  
obs. 
(thousand) parameter of D./ 
No. of  
obs. 
(thousand) parameter of D./ parameter of D./ 
No. of  
obs. 
(thousand) 
Internal care 0.181*** (0.024) 55.1 0.053** (0.025) 23.2 0.190*** (0.035) 0.0189 (0.021) 359.7 
Surgery 0.285*** (0.026) 49.8 0.108* (0.054) 7.5 0.160*** (0.040) 0.158*** (0.030) 359.7 
Traumatology 0.157*** (0.035) 41.1 -0.097 (0.090) 3.8 0.431*** (0.049) 0.0996*** (0.038) 359.7 
Gynaecology 0.211*** (0.029) 41.0 0.029 (0.040) 16.3 0.004 (0.061) 0.0462** (0.020) 359.7 
Paediatrics -0.265*** (0.042) 20.8 0.019 (0.050) 7.6 0.297*** (0.084) 0.0308 (0.028) 359.7 
Otolaryngology 0.355*** (0.027) 45.6 -0.010 (0.060) 6.6 0.516*** (0.081) -0.0649 (0.048) 359.7 
Ophtalmology  0.368*** (0.024) 55.4 0.040 (0.035) 14.1 0.554*** (0.143) 0.0390** (0.020) 359.7 
Dermatology 0.372*** (0.028) 40.2 0.192** (0.083) 5.7 0.420*** (0.071) 0.164*** (0.040) 359.7 
Neurology 0.267*** (0.034) 28.4 0.157*** (0.041) 8.1 0.199*** (0.028) 0.0149 (0.029) 359.7 
Orthopaedy 0.268*** (0.037) 24.0 0.075 (0.092) 3.6 0.265*** (0.033) 0.0645 (0.039) 359.7 
Urology 0.194*** (0.040) 20.7 0.044 (0.048) 4.2 0.280*** (0.032) 0.0370 (0.036) 359.7 
Rheumatology 0.361*** (0.029) 39.9 0.309*** (0.038) 13.0 0.202*** (0.020) 0.100*** (0.023) 359.7 
Psychiatry 0.286*** (0.047) 14.7 0.172*** (0.038) 10.5 0.182*** (0.026) 0.0434 (0.033) 359.7 
Pulmonology -0.232*** (0.020) 90.5 0.088** (0.043) 46.5 -0.158*** (0.049) -0.0451*** (0.014) 359.7 
Cardiology 0.308*** (0.036) 25.9 0.085* (0.044) 9.1 0.552*** (0.054) 0.00828 (0.054) 359.7 
Lab diagnostics 0.169*** (0.031) 66.1 0.108** (0.047) 19.8 0.524*** (0.116) 0.311*** (0.027) 359.7 
X-ray 0.220*** (0.018) 110.7 0.034 (0.033) 37.5 0.312*** (0.070) 0.129*** (0.013) 359.7 
Ultrasound 0.159*** (0.022) 72.4 0.063 (0.042) 17.7 0.249*** (0.049) 0.0975*** (0.016) 359.7 
Source: own calculations based on micro-level GYEMSZI data 
***: p<0.01; **: p<0.05; *: p<0.1 
Note: All results refer to outpatient cases excluding special one-day services and the inhabitants of one micro-region (Baktalórántháza), where the new unit started to operate 
only in May 2012. Robust standard errors are in parentheses.      
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FE logit model on the probabilities of visiting the doctor in a given year for people living in treated or control micro-regions. Controls: year dummy and age groups. The 
estimated parameters show the impact of the treatment on log\]/1 − ]^, hence tend to overestimate the impact on log ]. Number of periods: 2 years (2009 and 2012). 
Number of observations (patient x year) is shown, covering people with one zero and one non-zero case number in a given specialty.  
FE truncated Poisson model on individual zero-teruncated case numbers in a given year for people living in treated or control micro-regions. Controls: year dummy and age 
groups. The estimated parameter shows the impact of the treatment on the log expected value of a Poisson distribution on the basis of its zero-truncated part. Number of 
periods: 2 years (2009 and 2012). Number of observations (patient x year) is shown, covering people with positive case numbers in both periods in a given specialty.  
Pooled zero-inflated negative binomial model on case numbers for people living in treated or control micro-regions. Controls: year dummy, gender and age groups (0-17, 18-
39, 40-59, 60-69, 70+). The estimated parameters show the impact of the treatment on the log-odds of the probability of the non-zero (negative binomial) part and on the log 
expected value of the negative binomial part. Number of periods: 2 years (2009 and 2012). Number of observations (person x year) is shown.      
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APPENDIX 1: Derivation of the fixed-effects truncated Poisson estimator 
We use the notations of section 3.2. Let _&, _D, … , _F be independent Poisson random 
variables with _ = T, let T = ∑ TFW&  denote the sum of the Poisson-parameters and 
let 
]G = OPQ`IJabcdIb∑ OPQ`IeabcdIbfegh = OPQ`IJa
b
∑ OPQ`Ieabfegh . 
Note that ]G does not depend on the unobserved effect G. Then a well-known result 
(which is also standardly used to derive the existence of the fixed-effects Poisson estimator) 
states that the distribution of _&, _D, … , _F, conditional on ∑ _FW& = , is multinomial 
with parameters \, ]&G, … , ]FG^ (Johnson et al., 1997, p. 32). The truncated random 
variables C in section 3.2. can be obtained as C = @_|_ > 0A and hence the joint 
distribution of the truncated versions, C&, CD, … , CF, conditional on ∑ _FW& = ∑ CFW& =
, differs from the multinomial law only because neither marginal can take the value zero. 
Hence, this conditional distribution is truncated multinomial, as defined by Johnson et al. 
(1997), p. 72, with all marginals truncated at zero. By calculating the various joint 
probabilities of the zero marginals, the probability mass function of this distribution is given 
by 
Pr iC& = &, CD = D, … , CF = FjkC
F
W&
= l = ! ∗ ∏
]GJ!FW&1 − nG  
for 1 ≤  <   = 1, … , U integers such that  ∑ FW& = , where 
nG = ∑ −1F%q%&∑ r]hG + ⋯+ ]tGu{h,…,t}⊂{&,D,…,F}F%&qW& . 
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(For U = 2 we obtain the formula used by Majo and van Soest, 2011). These formulae do not 
depend on G, so ∑ CFW&  is a sufficient statistic for G. Therefore, the conditional log-
likelihood can be defined for observation i (after omitting the terms that do not depend on the 
parameters) as 
wxG = ∑ Clog	]xGFW& − log\1 − nxG^. 
Then, the fixed-effects truncated Poisson estimator of G is obtained by maximizing  
,xG =kwxG
y
W&
 
with respect to xG. Since the truncated Poisson distribution belongs to the exponential family 
of distributions, the conditional maximum likelihood framework developed by Andersen 
(1970) can be applied to derive that this fixed-effects estimator is consistent and 
asymptotically normally distributed. 
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APPENDIX 2: Data 
Table A1: Selection of control micro-regions: variables in the treated, control and non-
treated micro-regions and the coefficients of the propensity score model 
 
Treated Control All 
non-
treated 
 
 
 micro-regions   
Explanatory variables  
in the propensity score model 
Groupwise means  
(with S.D.) 
t-stat 
(treated 
– 
control)  
Logit coef. 
(with S.E.) 
Cars per 1000 inhabitants 
93.40 
(23.7) 
91.19 
(16.48) 
111.06 
(26.22) 0.34 
-0.0356 
(0.0401) 
Local tax  
per 1000 inhabitants (1000 HUF) 
10.81 
(7.18) 
10.34 
(5.36) 
23.13 
(18.09) 0.24 
-0.0424 
(0.0462) 
Local unemployment rate 
0.090 
(0.035) 
0.086 
(0.030) 
0.063 
(0.029) 0.33 
17.92 
(17.71) 
Regular cultural events  
in a year per inhabitants 
0.056 
(0.039) 
0.058 
(0.037) 
0.078 
(0.037) -0.21 
-25.38** 
(12.04) 
Fraction of persons  
aged 60 or over 
0.207 
(0.023) 
0.212 
(0.028) 
0.216 
(0.023) -0.64 
-26.95 
(17.55) 
General practitioners  
per 1000 inhabitants 
0.532 
(0.089) 
0.529 
(0.114) 
0.503 
(0.068) 0.08 
2.127 
(4.942) 
Fraction of  
high school graduates (%) 
22.24 
(4.77) 
22.34 
(4.12) 
28.89 
(8.01) -0.07 
0.323* 
(0.183) 
Population of the chief town  
(1000 inhabitants) 
6.34 
(2.87) 
6.91 
(4.19) 
26.52 
(34.55) -0.50 
-0.353 
(0.250) 
Fraction of inhabitants  
living in urban areas 
0.197 
(0.241) 
0.204 
(0.257) 
0.437 
(0.269) -0.09 
5.011 
(3.324) 
Av. dist. to the chief town of the  
micro-region (in minutes, by car) 
23.58 
(9.22) 
25.51 
(8.57) 
25.15 
(12.21) -0.69 
-0.0620* 
(0.0319) 
Weekly specialist hours in basic outpatient  
care per 1000 inhabitants in 2008 
0.570 
(0.894) 
1.200 
(1.508) 
3.789 
(4.581) -1.63 
-1.042*** 
(0.357) 
Population  
(1000 inhabitants) 
21.68 
(8.83) 
23.35 
(11.44) 
49.79 
(42.33) -0.52 
-0.0668 
(0.0490) 
Pro-government major  
in the chief town 
0.200 
(0.411) 
0.238 
(0.436) 
0.270 
(0.446) -0.29 
-0.191 
(0.927) 
Number of micro-regions 20 21 137  157 
Distribution of the propensity score      
Mean 0.591 0.366 0.067   
Standard deviation 0.228 0.270 0.170   
Minimum 0.140 0.094 0.000   
Maximum 0.954 0.898 0.898   
Source: own calculations based on TSTAR (settlement) and OEP data for year 2008 
*** p<0.01; ** p<0.05; * p<0.1 
Sample: Micro-regions outside Central Hungary (including the chief towns of the counties)  
Logit dependent variable: dummy variable representing new outpatient service locations under SIOP 2.1.2. 
t-statistic: usual t-statistic to test the equality of the averages in the treated and control micro-regions  
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Table A2: Average quarterly number of outpatient cases by patient in the treated and control 
micro-regions, 2008-2012 
  2008 2009 2010 2011 2012 
       
Overall 
Treated  1.126 1.138 1.114 1.280 1.411 
Control 1.221 1.235 1.197 1.219 1.225 
Gender: male 
Treated  0.928 0.950 0.928 1.049 1.132 
Control 1.003 1.020 0.985 0.999 0.999 
Gender: female 
Treated  1.307 1.311 1.285 1.493 1.668 
Control 1.421 1.432 1.392 1.420 1.432 
Age: 0-17 years 
Treated  0.634 0.662 0.654 0.744 0.786 
Control 0.646 0.669 0.667 0.685 0.692 
Age: 18-59 years 
Treated  1.113 1.107 1.064 1.206 1.316 
Control 1.195 1.204 1.141 1.143 1.134 
Age: at least 60 years 
Treated  1.617 1.640 1.622 1.882 2.098 
Control 1.798 1.787 1.757 1.799 1.805 
Source: own calculations based on micro-level GYEMSZI data 
Note: outpatient cases excluding special one-day services.  
 
Event-level data set: The original event-level data set contains administrative information for 
a 25 per cent random sample of all residents of 20 treated and 21 control micro-regions who 
showed up at least once in the health care administrative databases during the period. The 
comparison of the population of the micro-regions to the sample size of our data set suggests 
that around 10% of people never visited an inpatient or outpatient service between 2008 and 
2012 and hence do not show up in our administrative records. However, these missing cross-
sectional observations would not contribute to the estimation of the fixed-effects models and 
do not bias the results (see section 3). 
Data cleaning: The origonal data set included many variables, but the additional dimensions 
played a role only in data cleaning. For instance, the knowledge of the department and the 
specialty of the case enabled us to exclude the special one-day inpatient services administered 
within the outpatient system (e.g. infusion treatments) from the analysis and rather 
concentrate on „traditional” outpatient provision. In the paper all results are calculated 
without these one-day services. 
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Treatment of deaths and migration: The fact that a particular person did not have an 
outpatient record during a quarter does not necessarily imply that he / she was present in the 
micro-region but did not visit the doctor. However, in the vast majority of records this is a 
reasonable assumption. Therefore, zero cases in a particular quarter were imputed for a person 
if there was no contradictory information. We used three types of contradictory information to 
exempt someone from being considered as not visiting the doctor in the relevant period: 1) 
periods before the date of birth, 2) periods after the known date of death, 3) periods after 
switching residence to a postcode outside of the treated and control regions. This rule is not 
completely correct since we observe a death only if it occured in a hospital and we observe 
the location of residence only when a person takes up an inpatient or outpatient service. 
However, as the majority of deaths occur in a hospital and migration is not widespread in the 
(older) population that uses health services more frequently, this imputation rule seems to be a 
reasonable method for creating the panel data set. This is also suggested by the fact that the 
overall results obtained from the semi-aggregate and micro-level data are very similar (see 
section 4). 
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APPENDIX 3: Robustness of the fixed-effects truncated Poisson estimator 
When investigating the robustness properties of the fixed-effects truncated Poisson estimator, 
we use a setup similar to our empirical example. To analyse convergence, the number of cross 
sectional units is chosen as z = 1000 or z = 10000. There are two periods  = 1, 2. The 
vector of explanatory variables, , consists of the constant and a dummy variable , for 
which  = 1 if  = 2 and { > z/2, and  = 0 otherwise.13 The conditional expectation 
equation (10) is:14   
T = exp	−2 + 1 ∗  + G.  
We observe C = @_|_ > 0A. Here, the probability distribution of _|, G, | is 
conditionally Poisson with expectation | ∗ T, where | is the mixing random variable. We 
assume that ||, G is conditionally independent across i and t and ||, G = 1. 
(Hence, _|, G = T.  We also assume that _&, _D is independent conditional on 
&, D, G, |&, |D.   
We use a variety of distributions to simulate the mixing variable |.  
a) In the simplest case, | is independent identically Gamma-distributed with parameter 
}, } (this choice ensures that it has a unit expected value).15 Since the negative 
binomial distribution is a Gamma-mixture of Poisson distributions, _|, G is 
negative binomial in this case. We choose } = 0.5.  
                                                          
13
 This choice mirrors our empirical setting where roughly half of the units are treated in the second period. 
14
 The reason behind this choice is that the non-robustness of the fixed-effects truncated Poisson estimator should 
show up if the truncation has a relatively large role, i.e. if μ./ is close to zero (because the usual fixed-effects 
Poisson estimator is robust to all misspecifications analysed here). 
15 With this parametrization the probability density function is given by  =  %&% for  > 0. 
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b) In other simulations | is lognormal with parameters , D, where – to ensure the 
unit expected value – the condition  + ID = 0 holds. Our parameter choices:  
1)  = −1/2, D = 1) 
2) Or we allow the distribution of | to depend on &, D by choosing 
 = −1/2, D = 1 for { ≤ z/2 and  = −1/8, D = 1/4 for { > z/2. 
(Note that the distribution of | still does not depend on t.) 
c) Finally, we allow the distribution of | to depend on t as well by choosing α./ as a 
Gamma random variable with parameter 1,1 for t = 1 and with parameter 1/2, 1/
2 for t = 2. (Note that | = 1 still holds.) 
For the simulation of G, we first note that (just like |) the value expG enters 
multiplicatively into the expression of the mixed Poisson-parameter | ∗ T. Hence we may 
use similar mixing distributions for simulating expG as for simulating | above. (There is 
one major difference: not even the simulated random variable – let alone the distribution – of 
expG depends on t.) Thus we use the above choices a/1, b/1, and additionally – to allow a 
nonzero correlation between G and  – a modified choice, b/2’:16 
b)  2’) expG is lognormal with parameter  = −1/2, D = 1 for { ≤ z/2 and 
 = 1/2, D = 1 for { > z/2. 
Table A3 shows the summary statistics of the conditional maximum likelihood estimates 
obtained for 1000 simulated panel data sets for each choice of z, | and expG above. 
According to the Table, if the underlying distribution is a mixture of Poisson with the same 
distribution across time but with possibly different distributions across cross sectional units 
                                                          
16 Note that here we may allow expG ≠ 1. 
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(choices a., b/1. and b/2. above, i.e. the first nine rows), then the estimated parameters are 
within a 0.01 wide interval around the true value (G = 1 in large sample sizes (z = 10000), 
and the empirical standard errors of the estimates are very close to the average robust standard 
errors calculated by the maximum likelihood routine.17 This suggests that the fixed-effects 
truncated Poisson estimator is consistent in this setting, and the robust standard errors 
calculated from likelihood theory approximate the true uncertainty well.  
At the same time, Table A3 also shows that the robustness property does not hold in a more 
general setting: the estimator does not appear to be consistent if the distribution of the mixing 
variable | depends on t as well (case c., i.e. the last three rows). 
Table A3: Simulation results for the fixed-effects truncated Poisson-estimator 
  z = 1000 z = 10000 
| expG Mean (G) S.D. (G) Rob S.E. (ML) z-stat. Mean (G) S.D.  (G) Rob S.E. (ML) z-stat. 
a 
a 1.0176 0.2407 0.2391 2.31 1.0082 0.0797 0.0776 3.26 
b / 1 1.0000 0.2489 0.2365 0.00 1.0099 0.0782 0.0782 4.00 
b / 2’ 0.9995 0.1912 0.1827 -0.08 0.9974 0.0602 0.0614 -1.38 
b / 1 
a 1.0091 0.2565 0.2347 1.13 1.0036 0.0792 0.0782 1.42 
b / 1 1.0302 0.2449 0.2304 3.90 1.0070 0.0816 0.0781 2.71 
b / 2’ 1.0076 0.1858 0.1763 1.29 0.9949 0.0628 0.0607 -2.58 
b / 2 
a 1.0208 0.2046 0.1956 3.21 1.0035 0.0620 0.0616 1.76 
b / 1 1.0161 0.2014 0.1969 2.52 1.0041 0.0638 0.0622 2.05 
b / 2’ 1.0036 0.1224 0.1214 0.93 0.9996 0.0389 0.0394 -0.33 
c 
a 1.0569 0.2375 0.2262 7.57 1.0468 0.0734 0.0726 20.16 
b / 1 1.0509 0.2338 0.2261 6.89 1.0431 0.0723 0.0733 18.85 
b / 2’ 1.0357 0.1820 0.1709 6.20 1.0429 0.0562 0.0558 24.17 
Source: own calculations 
Results for 1000 simulations in each case.  
Note: z-stat = (Mean-1)/S.D.; Rob. S. E.: average standard errors calculated by the ML routine.   
                                                          
17 It should be noted, however, that a formal z-test rejects the null hypothesis βO/ = 1 at a 5% level in six out of 
the nine cases. For n = 1000 the standard errors are larger and the z-test rejects the null hypothesis at the 5% 
level in four cases out of the nine. 
